Patent US4778751A successfully refreshed from Google Patents.
US4778751A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method for measuring antigens or antibodies in biological fluids using ligand labeled antigens or ligand labeled antibodies
Assignee: Siemens Medical Solutions Diagnostics Inc Canada
•
Filing: 1986-05-12
•
Granted: 1988-10-18
•
Expires: 2006-05-12
Abstract
Abstract The method of measuring circulating antigens or antibodies by using a ligand labeled specific antigen or ligand labeled specific antibody chemically attached to a soluble matrix or backbone, a differently labeled anti-antigen or anti-antibody and a solid phase anti-ligand directed at the ligand attached to the specific antigen or specific antibody. This is achieved by either one or two analytical schemes: (a) Reacting a patient sample with a ligand labeled specific antigen or a ligand labeled specific antibody in the liquid phase in the presence of a differently labeled specific anti-antigen or labeled specific anti-antibody. This immunological complex is reacted with an immobilized anti-ligand on a solid support which is directed against the ligand attached to the specific antigen or antibody through the liquid matrix. Subsequently the solid phase is washed and checked for the label on the anti-antigen or anti-antibody which is directly proportional to the concentration of specific antigen or antibody. (b) Reacting a patient sample with the ligand labeled specific antigen or a ligand labeled specific antibody in the liquid phase, then contacting said liquid phase with an immobilized anti-ligand on a solid support; washing the solid support and reacting it with a differently labeled anti-antigen or anti-antibody. This is followed by re-washing of the solid support and checking for the presence of the label attached to the anti-antigen or anti-antibody which is directly proportional to the concentration of the specific antigen or antibody. The ligand is covalently attached to the specific antigen or antibody through a soluble liquid matrix or backbone to which the specific antigen or antibody has been chemically attached. This invention is applicable to a wide variety of antigen or antibody detection as described herein.
Inventors
- 👤 A. Said El Shami
- 👤 Olusola O. Alaba
- 👤 Charles A. Kasal
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-31 07:37
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/543; G01N33/54306; G01N33/531; G01N33/536; G01N33/537; G01N33/538; G01N33/544; G01N33/548; Y; Y10; Y10S; Y10S435/00; Y10S435/805; Y10S435/971; Y10S436/00; Y10S436/823
Claims Analysis
Total Claims: 15
Claim 1
Independent Claim
203 words
A method for measuring the level of an antigen (Ag 1 ), antibody (Ab 1 ) or hapten (H) in a liquid sample, which sequentially comprises: (a) forming in a liquid phase reaction a soluble complex wherein said antigen (Ag 1 ), antibody (Ab 1 ) or hapten (H) is linked through, respectively, a specific antibody (Ab), antigen (Ag) or antihapten (Anti-H), to a matrix which is soluble in the liquid phase and carries a ligand (X), said matrix capable of being chemically attached to more than one specific antibody (Ab), antigen (Ag) or antihapten (Anti-H); (b) forming an insolubilized complex comprising a solid support linked to the ligand (X) of said soluble complex through an anti-ligand (Y), the insolubilized complex carrying a label (Z) linked to the antigen (Ag 1 ) through an anti-antigen (Anti-Ag 1 ), to the antibody (Ab 1 ) through an anti-antibody (Anti-Ab 1 ) or to the hapten (H); (c) washing the insolubilized complex; and (d) observing the washed insolubilized complex for the presence of the label (Z) wherein the presence of the label (Z) is an indication of the level of said antigen (Ag 1 ), antibody (Ab 1 ) or hapten (H) in said sample.
Claim 2
Independent Claim
203 words
A method for measuring the level of an antigen (Ag 1 ), antibody (Ab 1 ) or hapten (H) in a liquid sample, which sequentially comprises: (a) forming in a liquid phase reaction a soluble complex wherein said antigen (Ag 1 ), antibody (Ab 1 ) or hapten (H) is linked through, respectively, a specific antibody (Ab), antigen (Ag) or antihapten (Anti-H), to a matrix which is soluble in the liquid phase and carries a ligand (X), said matrix capable of being chemically attached to more than one specific antibody (Ab), antigen (Ag) or antihapten (Anti-H); (b) forming an insolubilized complex comprising a solid support linked to the ligand (X) of said soluble complex through an anti-ligand (Y), the insolubilized complex carrying a label (Z) linked to the antigen (Ag 1 ) through an anti-antigen (Anti-Ag 1 ), to the antibody (Ab 1 ) through an anti-antibody (Anti-Ab 1 ) or to the hapten (H); (c) washing the insolubilized complex; and (d) observing the washed insolubilized complex for the presence of the label (Z) wherein the presence of the label (Z) is an indication of the level of said antigen (Ag 1 ), antibody (Ab 1 ) or hapten (H) in said sample.
Claim 3
Dependent Claim
26 words
A method according to claim 1 wherein the label (Z) is an enzymatic label, a radioactive label, a fluorescent label, chemiluminescent label or a bioluminescent label.
Claim 4
Dependent Claim
38 words
A method according to claim 1 or 2 wherein the matrix is a soluble carbohydrate with a molecular mass of from 6,000 to 80,000 daltons or a Ficoll with a molecular mass of from 70,000 to 400,000 daltons.
Claim 5
Dependent Claim
12 words
A method according to claim 3 wherein the matrix is a dextran.
Claim 6
Dependent Claim
27 words
A method according to claim 1 or 2 wherein the matrix is a soluble polymer or copolymer with a molecular mass of from 5,000 to 200,000 daltons.
Claim 7
Independent Claim
23 words
A method according to claims 1 or 2 wherein the ligand (X) is covalently attached to the matrix through an amino acid copolymer.
Claim 8
Independent Claim
40 words
A method according to claims 1 or 2 wherein the ligand (X) is avidin, the solid support is a tube coated with avidin, and biotin is added to effect the immobilization of the soluble complex onto the avidin coated tube.
Claim 9
Independent Claim
43 words
A method according to claims 1 or 4 wherein the ligand (X) is biotin, the solid support is a tube coated with an anti-avidin antibody, and avidin is added to effect the immobilization of the soluble complex onto the anti-avidin antibody coated tube.
Claim 10
Independent Claim
46 words
A method according to any one of claims 1 to 6 wherein the ligand (X) is biotin, the solid support is a coated tube coated with biotinylated protein, and avidin is added to effect the immobilization of the soluble complex onto the biotinylated protein coated tube.
Claim 11
Independent Claim
59 words
A method according to claims 1 or 2 wherein the ligand (X) is selected from hapten, avidin and bovine serum albumin, and the anti-ligand (Y) is selected from anti-hapten, anti-avidin and anti-bovine serum albumin, respectively, and wherein the hapten is selected from biotin, fluoresceine and dinitrophenol, and the anti-hapten is selected from avidin or anti-biotin, anti-fluoresceine and anti-dinitrophenol, respectively.
Claim 12
Independent Claim
32 words
A method according to claims 1 or 2 wherein the ligand (X) is covalently attached to the matrix, and the specific antibody (Ab) or antigen (Ag) is chemically attached to the matrix.
Claim 13
Independent Claim
114 words
A method according to claims 1 or 2 wherein the sample contains an antigen (Ag 1 ) or antibody (Ab 1 ), the soluble complex is formed by reacting the sample in the liquid phase with said matrix carrying ligand (X) and specific antibody (Ab) or antigen (Ag) in the presence of an anti-antigen (Anti-Ag 1 ) or anti-antibody (Anti-Ab 1 ) labelled with said label (Z) to form said soluble complex, reacting this soluble complex with immobilized anti-ligand (Y) on a solid support to form an insolubilized complex, washing the insolubilized complex, and observing the washed insolubilized complex for the label (Z) on the anti-antigen (Anti-Ag 1 ) or anti-antibody (Anti-Ab 1 ).
Claim 14
Independent Claim
125 words
A method according to claims 1 or 2 wherein the sample contains an antigen (Ag 1 ) or antibody (Ab 1 ), the soluble complex is formed by reacting the sample in the liquid phase with a said matrix carrying said ligand (X) and said specific antibody (Ab) or antigen (Ag), the insolubilized complex is formed by contacting said soluble complex with immobilized anti-ligand (Y) on a solid support to form an insolubilized complex, washing the insolubilized complex, reacting it with an anti-antigen (Anti-Ag 1 ) or anti-antibody (Anti-Ab 1 ) labelled with said label (Z), rewashing the resulting insolubilized complex, and observing the washed insolubilized complex for the presence of the label attached to the anti-antigen (Anti-Ag 1 ), or anti-antibody (Anti-Ab 1 ).
Claim 15
Independent Claim
106 words
A method according to claims 1 or 2 wherein the sample contains a hapten (H), the soluble complex is formed by reacting the sample in the liquid phase with a said matrix carrying ligand (X) and a specific anti-hapten (Anti-H) in the presence of a labeled hapten probe (H-Z), allowing competitive binding to occur between the hapten (H) in the sample and the labeled hapten probe (H-Z) for anti-hapten (Anti-H) binding sites on the matrix, reacting the resulting soluble complex with immobilized anti-ligand (Y) on a solid support to form an insolubilized complex, washing insolubilized complex, and observing the washed insolubilized complex for the label (Z).
References Cited (Backward Citations)
US4343896A
Cited
US4495296A
Cited
US4281061A
Cited
US4401764A
Cited
US4508830A
Cited
US4506009A
Cited
US4522922A
Cited
US4530900A
Cited
US4595661A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1991-10-18 | 1992-04-18 | 1992-10-18 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1995-10-18 | 1996-04-18 | 1996-10-18 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1999-10-18 | 2000-04-18 | 2000-10-18 | $7700.00 | Window Closed / Lapsed |